Pfizer CEO Albert Bourla told The Atlantic Tuesday that the timeline on shots for children ages 5 to 11 is up to the FDA.
“I think it’s not appropriate for me to comment how long FDA will take to review the data. They should take as much time as they think it’s appropriate for them to have high levels of comfort,” Bourla said.
“If approved, we will be ready to have the vaccine available,” he added.
Vaccines may be authorized and available for 5- to 11-year-olds in October or November.
Bourla said he thinks once kids get vaccinated, the U.S. will get a “strong push” toward herd immunity.
Bourla said he thinks booster protection from Pfizer vaccines will likely last one year.
-ABC News’ Cheyenne Haslett
